The French-American-British subtype acute myelomonocytic leukemia with abnormal eosinophils (FA6 AML M4Eo) with pericentric inversion of chromosome 16 is cytomorphologically defined by a myelomonoblastic blast population and abnormal eosinophils. Until now, it remained an open question whether these abnormal eosinophils are part of the malignant clone or an epiphenomenon. We analyzed five cases of AML M4Eo with inv(l6) and combined May-Grunwald-Giemsa staining with fluorescence in situ hybridization CUTE MYELOMONOCYTIC leukemia with abnormal eosinophils (French-American-British [FABIclassification AML M4Eo) is a distinct subtype of acute myeloid leukemias (AMLs) carrying specific morphological, cytogenetic, clinical, and prognostic features."6 The bone marrow (BM) morphology is characterized by a myeloblastic/monoblastic infiltration accompanied by a more or less significant fraction of abnormal eosinophils. They are detectable in the BM in nearly every case and sometimes can be found in the peripheral blood (PB) as we1L6 These abnormal eosinophils show large, more irregular, deeply purple-staining granules, usually admixed with normal-appearing eosinophil granules. Abnormal eosinophils have distinct staining and cytochemical properties; in contrast to normal eosinophils, they are reactive for naphthol-AS-D-chloroacetate-esterase staining and have a stronger reaction to periodic acid Schiff than do normal eosinophil^.^"^ In 1982, Arthur and Bloomfield first reported on the association of BM eosinophilia and structural changes of chromosome 16.*,13 In 1983, Le Beau et a13 showed that a pencentric inversion inv( 16)(p13q22) is consistently present in the AML M4 with abnormal marrow eosinophils. The association between morphology and cytogenetics is so strong that one can accurately predict the cytogenetic result of inv(l6) in almost every case of AML M4Eo and vice versa. In 1985, this new subtype of AML was added to the revised FAB classification.' Recently, breakpoint cloning identified the CBFB gene coding for the human homolog of a mouse transcription factor CBFB, also called PEBFQ , and the MYH 11 gene coding for a smooth muscle form of myosin heavy chain. The fusion transcript can now be detected by polymerase chain reaction (FCR).'"18 Furthermore, a yeast artificial chromosome (YAC) isolated during breakpoint cloning can be used for fluorescence in situ hybridization (FISH) in cases with inv( 16)(~13q22).'~*'~ Until now, it remained unclear whether or not the abnormal eosinophils are part of the malignant cell population or are a result of a secondary response, an epiphenomenon.'9 To answer this remaining question, we used a combination of standard May-Griinwald-Giemsa (MGG) staining and FISH to investigate abnormal eosinophils on the single-cell level and were able to show the inv( 16) signals in abnormal eosinophils.
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FISH. For FISH studies, the YAC 854E2 first described by Liu et all4 was obtained from Centre d'Etude du Polymorphisme Humain (CEPH; Paris, France). The probe was biotinylated by nick-translation using the BioNick kit (BRL, Rockville, MD) according to manufacturer's instructions. This YAC binds to chromosome band 1 6~1 3 spanning the breakpoint involved in the inv(16)(p13q22). Therefore, in interphase cells with inv(l6) the hybridization signal is split and the cells contain three instead of two signals (Fig I) . In four cases, metaphases were additionally studied by FISH.
Combination of MGG and FISH. The combination of MGG staining and HSH was performed according to Anastasi et aI2* with modifications. After MGG staining, the smears were covered with Pertex mounting medium (Medite, Wolfratshausen, Germany), and morphological analysis was performed. was documented by the "mark and find system" (Zeiss). For FISH, coverslips were carefully removed after incubation in xylene for S minutes. Slides were fixed in Camoy's fixative (methanokacetic acid, 3: I ) for 15 minutes, washed in phosphate buffer for 1 minute, and fixed again in paraformaldehyde for I minute. After dehydration in ethanol (70%, 85%, IOO%), FISH was performed according to a protocol published e l~e w h e r e .~' .~~ In brief, in situ hybridization was conducted as follows: 1 pL of hybridization mixture (0.5 ng biotinylated YAC DNA-probe, 100 pg human Cot-DNA, 10% dextran sulfate, 60% formamide, 1 X SSC [O.lS moln NaCl and 0.01.5 mol/L natriumcitrate, pH 71) was placed on the area of the smear with the photographed cells, covered with a IO-mm round cover slip, and sealed with rubber cement. Slides and probes were denaturated simultaneously at 75°C for 3 minutes and hybridized at 37°C overnight. After hybridization, the slides were washed 3 times in 0. I x SSC at 60°C for I O minutes each, followed by a brief equilibration in phosphate buffer at room temperature. The probe was detected by fluorescein isothiocyanate-conjugated avidin (JacksonlDianova, Hamburg, Germany) followed by biotinylated goat anti-avidin-DN (Vector, Burlingame, CA). Amplification was performed by repeating both detection steps. Nuclei were counterstained by propidiumiodide (0.5 ng; Sigma, Deisenhofen, Germany) and slides were covered with an antifade medium (90% [vol/vol] For evaluation of the signal constellation of the abnormal eosinophils, previously photographed cells were relocated by the "mark and find system" (Zeiss). The results were documented using conventional microphotography and the ISIS imaging system (MetaSysterns, Sandhausen, Germany).
RESULTS
Cytomorphological studies. All cases were classified as AML M4Eo by standard cytomorphology. Abnormal eosinophils were detected in 3% to 25% in all BM specimens (mean, 15%; see Table 1 For personal use only. on September 14, 2017. by guest www.bloodjournal.org From FISH studies. In three cases, metaphases could be analyzed after FISH. In 18 of 28 (64%) metaphases, a split signal was present on the aberrant chromosome 16 (Fig 3) .
On BM smears, 100 to 300 interphase cells were investigated for the number of hybridization signals. The percentage of cells with the typical signal constellation of inv(16)(p13q22) ranged between 20.5% and 36.3% (mean, 27.5%; see Table 1 ).
In two cases, only one BM smear was available, and this was used for interphase FISH studies only; we were not able to combine MGG and FISH in these cases. In the other three cases, we combined the standard MGG staining with the FISH technique on blood or BM smears to investigate the signal constellation in abnormal eosinophils. Even where the hybridization signals were sometimes very weak in hypercellular areas on the BM smears, we were able to show that 56%, 63%, and 78% of the previously identified abnormal eosinophils contained three hybridization signals (Figs 4A and B). Until now, it remained unclear whether or not the abnormal eosinophil is part of the malignant cell population.10"2.'y Recently, the state of the art was summarized by Liu et a1 in an excellent review." One study suggested the involvement of abnormal eosinophils in the malignant process by using metaphase analysis.*' Eosinophilic-stained granules were scattered beneath the metaphases with an inverted chromosome 16, leading to the assumption that the abnormal eosinophils belong to the aberrant clone. In another in vitro study, cells from the ME-l cell line derived from a patient with AML M4Eo were induced to differentiate into eosinophils, which were shown to contain an i n~( 1 6 ) .~* .~~ However, it is not clear whether these cells correspond to the abnormal eosinophils in vivo. Thus, our starting point was the abnormal eosinophil detectable on routine BM or blood smears of five patients with AML M4Eo and inv(16)(p13q22). We combined the standard cytomorphological MGG staining with the FISH technique on air-dried smears. Using a "mark and find system" for every cell, we were able to prove that abnormal eosinophils carry the inversion 16 signals and, therefore, are clearly identified as a part of the leukemic cell population.
Given that specific probes are available for FISH analysis, this combination of cytomorphology and FISH obviously is useful for the detection of cell lineage-specific involvement in acute and chronic leukemia^.'""^ It may also help to identify the origin of suspicious cells in the BM at the time of complete remission; therefore, it can be used for the detection of minimal residual disease.22.30.'s"6
